Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

HIGHLIGHTS

• who: Albert Prats-Uribe and collaborators from the umifenovir (0% in the US, South Korea, and Spain have published the paper: Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study, in the Journal: (JOURNAL) of 28/03/2020
• what: For the main results, the authors focused on drugs covered in the living World Health Organization guideline for drugs-hydroxychloroquine, lopinavir combined with ritonavir, remdesivir, and dexamethasone.7 The authors further explored this (see supplemental figure 1) and found that the drugs the authors focused on were not typically . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.